List of Tables
    Table 1. Blood Plasma Derivatives Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Blood Plasma Derivatives Market Trends
    Table 3. Blood Plasma Derivatives Market Drivers
    Table 4. Blood Plasma Derivatives Market Challenges
    Table 5. Blood Plasma Derivatives Market Restraints
    Table 6. Global Blood Plasma Derivatives Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Blood Plasma Derivatives Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Blood Plasma Derivatives Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Blood Plasma Derivatives Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Blood Plasma Derivatives Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Blood Plasma Derivatives Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Blood Plasma Derivatives Revenue Share by Player, 2017-2022
    Table 13. Global Blood Plasma Derivatives Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Blood Plasma Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2021)
    Table 15. Top Players of Blood Plasma Derivatives in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Blood Plasma Derivatives Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Blood Plasma Derivatives Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Blood Plasma Derivatives Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Blood Plasma Derivatives Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Blood Plasma Derivatives Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Blood Plasma Derivatives Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Blood Plasma Derivatives Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Blood Plasma Derivatives Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Blood Plasma Derivatives Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Blood Plasma Derivatives Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Blood Plasma Derivatives Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Blood Plasma Derivatives Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Grifols Company Details
    Table 31. Grifols Business Overview
    Table 32. Grifols Blood Plasma Derivatives Product
    Table 33. Grifols Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 34. Grifols Recent Development
    Table 35. SK Plasma Company Details
    Table 36. SK Plasma Business Overview
    Table 37. SK Plasma Blood Plasma Derivatives Product
    Table 38. SK Plasma Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 39. SK Plasma Recent Development
    Table 40. Fusion Health Care Company Details
    Table 41. Fusion Health Care Business Overview
    Table 42. Fusion Health Care Blood Plasma Derivatives Product
    Table 43. Fusion Health Care Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 44. Fusion Health Care Recent Development
    Table 45. Biotest AG Company Details
    Table 46. Biotest AG Business Overview
    Table 47. Biotest AG Blood Plasma Derivatives Product
    Table 48. Biotest AG Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 49. Biotest AG Recent Development
    Table 50. Green Cross Corporation Company Details
    Table 51. Green Cross Corporation Business Overview
    Table 52. Green Cross Corporation Blood Plasma Derivatives Product
    Table 53. Green Cross Corporation Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 54. Green Cross Corporation Recent Development
    Table 55. Baxter International Company Details
    Table 56. Baxter International Business Overview
    Table 57. Baxter International Blood Plasma Derivatives Product
    Table 58. Baxter International Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 59. Baxter International Recent Development
    Table 60. LFB Company Details
    Table 61. LFB Business Overview
    Table 62. LFB Blood Plasma Derivatives Product
    Table 63. LFB Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 64. LFB Recent Development
    Table 65. Octapharma AG Company Details
    Table 66. Octapharma AG Business Overview
    Table 67. Octapharma AG Blood Plasma Derivatives Product
    Table 68. Octapharma AG Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 69. Octapharma AG Recent Development
    Table 70. CSL Limited Company Details
    Table 71. CSL Limited Business Overview
    Table 72. CSL Limited Blood Plasma Derivatives Product
    Table 73. CSL Limited Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 74. CSL Limited Recent Development
    Table 75. Takeda Company Details
    Table 76. Takeda Business Overview
    Table 77. Takeda Blood Plasma Derivatives Product
    Table 78. Takeda Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 79. Takeda Recent Development
    Table 80. China Biologic Products Company Details
    Table 81. China Biologic Products Business Overview
    Table 82. China Biologic Products Blood Plasma Derivatives Product
    Table 83. China Biologic Products Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 84. China Biologic Products Recent Development
    Table 85. Kedrion Biopharma Company Details
    Table 86. Kedrion Biopharma Business Overview
    Table 87. Kedrion Biopharma Blood Plasma Derivatives Product
    Table 88. Kedrion Biopharma Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 89. Kedrion Biopharma Recent Development
    Table 90. BDI Pharma Company Details
    Table 91. BDI Pharma Business Overview
    Table 92. BDI Pharma Blood Plasma Derivatives Product
    Table 93. BDI Pharma Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 94. BDI Pharma Recent Development
    Table 95. Bayer AG Company Details
    Table 96. Bayer AG Business Overview
    Table 97. Bayer AG Blood Plasma Derivatives Product
    Table 98. Bayer AG Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 99. Bayer AG Recent Development
    Table 100. Hualan Biological Engineering Company Details
    Table 101. Hualan Biological Engineering Business Overview
    Table 102. Hualan Biological Engineering Blood Plasma Derivatives Product
    Table 103. Hualan Biological Engineering Revenue in Blood Plasma Derivatives Business (2017-2022) & (US$ Million)
    Table 104. Hualan Biological Engineering Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Blood Plasma Derivatives Product Picture
    Figure 2. Global Blood Plasma Derivatives Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Blood Plasma Derivatives Market Size 2017-2028 (US$ Million)
    Figure 4. United States Blood Plasma Derivatives Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Blood Plasma Derivatives Market Size 2017-2028 (US$ Million)
    Figure 6. United States Blood Plasma Derivatives Market Share in Global 2017-2028
    Figure 7. Blood Plasma Derivatives Report Years Considered
    Figure 8. Product Picture of Albumin
    Figure 9. Product Picture of Factor VIII
    Figure 10. Product Picture of Factor IX
    Figure 11. Product Picture of Immunoglobulin
    Figure 12. Product Picture of Hyperimmune Globulin
    Figure 13. Product Picture of Others
    Figure 14. Global Blood Plasma Derivatives Market Share by Type in 2022 & 2028
    Figure 15. Global Blood Plasma Derivatives Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Blood Plasma Derivatives Market Share by Type (2017-2028)
    Figure 17. United States Blood Plasma Derivatives Market Share by Type in 2022 & 2028
    Figure 18. United States Blood Plasma Derivatives Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Blood Plasma Derivatives Market Share by Type (2017-2028)
    Figure 20. Product Picture of Hospitals
    Figure 21. Product Picture of Clinics
    Figure 22. Product Picture of Other End Users
    Figure 23. Global Blood Plasma Derivatives Market Share by Application in 2022 & 2028
    Figure 24. Global Blood Plasma Derivatives Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Blood Plasma Derivatives Market Share by Application (2017-2028)
    Figure 26. United States Blood Plasma Derivatives Market Share by Application in 2022 & 2028
    Figure 27. United States Blood Plasma Derivatives Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Blood Plasma Derivatives Market Share by Application (2017-2028)
    Figure 29. North America Blood Plasma Derivatives Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Blood Plasma Derivatives Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Blood Plasma Derivatives Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Blood Plasma Derivatives Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Blood Plasma Derivatives Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E Blood Plasma Derivatives Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Grifols Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 58. SK Plasma Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 59. Fusion Health Care Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 60. Biotest AG Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 61. Green Cross Corporation Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 62. Baxter International Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 63. LFB Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 64. Octapharma AG Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 65. CSL Limited Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 66. Takeda Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 67. China Biologic Products Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 68. Kedrion Biopharma Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 69. BDI Pharma Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 70. Bayer AG Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 71. Hualan Biological Engineering Revenue Growth Rate in Blood Plasma Derivatives Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed